Brief: Lee's Pharmaceutical Sees Unaudited Net Profit Attributable Between HK$40 And HK$90Mln For Year
20/03/2023 12:14
March 20 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* SEES UNAUDITED NET PROFIT ATTRIBUTABLE OF BETWEEN HK$40
MILLION
AND HK$90 MILLION FOR YEAR
* EXPECTED RESULT DUE TO ABSENCE OF ONE-OFF GAIN, AMONG
OTHERS
Source text for Eikon: ID:
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals